Network Audit – Results vs Remedies

Network Audit – Results vs Remedies A white paper on pharmacy audit & investigations Understanding your audit and investigative program – is it working for you? In many cases, we see our audit and investigative reports and check a box that our vendors are managing the network and preventing Fraud, Waste, and Abuse (FWA). Running…

Read More

Lilly and Novo Nordisk to cut insulin Prices

Lilly and Novo Nordisk to cut insulin Prices A white paper on what this means to medication cost management What was the change? Both Lilly and Novo Nordisk have announced that their companies will reduce the price of several branded insulin products by as much as 75%. Novo’s decision on March 14th followed closely after Eli…

Read More

Manufacturer Funding Changes & Challenges

Manufacturer Funding Changes & Challenges A white paper on the opposing thoughts on patient assistance What is happening in the world of manufacturer funding assistance? We previously wrote a white paper on the ups and downs of manufacturer funding assistance – read that article on our Industy Insights section of PayerAlly.com. Now, we are taking…

Read More

Gene Therapy – “Therapy” Not Medication

Gene Therapy – “Therapy” Not Medication A white paper on understanding gene therapy What is Gene Therapy? Gene therapy is all the BUZZ in conversations about medication cost control and yet it is not a medication. So what is gene therapy and what makes it different than the ‘medications’ of the past. Why should we…

Read More

Manufacturer Funding – The Ups & Downs

Manufacturer Funding – The Ups & Downs A white paper on manufacturer funding Why is manufacturer subsidized funding a ‘big deal’? There has been a great deal of commentary on manufacturer funding, and how plans are using the funding to do more to offset patient cost share amounts. In this white paper, we are going…

Read More

The Ins and Outs of PBM Audit

The Ins and Outs of PBM Audit A white paper on pharmacy audit & investigations Understanding your audit and investigative program – is it working for you? In many cases, we see our audit and investigative reports and check a box that our vendors are managing the network and preventing Fraud, Waste, and Abuse (FWA).…

Read More

Administrative Fees or Percent of Value

Administrative Fees or Percent of Value A brief discussion on paying for medication management services Do Vendor Payment Models Support a Drive to Lowest Net Cost? In many cases, we see our audit and investigative reports and check a box that our vendors are managing the network and preventing Fraud, Waste, and Abuse (FWA). Running…

Read More